Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.

PubWeight™: 1.71‹?› | Rank: Top 3%

🔗 View Article (PMID 19477581)

Published in Eur Urol on May 19, 2009

Authors

Niels M Graafland1, Joost A P Leijte, Renato A Valdés Olmos, Cornelis A Hoefnagel, Hendrik J Teertstra, Simon Horenblas

Author Affiliations

1: Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Articles by these authors

EAU penile cancer guidelines 2009. Eur Urol (2010) 3.03

Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol (2011) 2.90

Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder. Int J Urol (2012) 2.76

Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol (2007) 2.68

Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol (2007) 2.44

Identification of high risk pathological node positive penile carcinoma: value of preoperative computerized tomography imaging. J Urol (2011) 2.42

The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging (2013) 2.25

Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: implications for the extent of inguinal lymph node dissection. Eur Urol (2008) 2.19

Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients? J Urol (2012) 2.14

Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla. Ann Surg Oncol (2013) 2.08

Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle. BJU Int (2013) 2.06

Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol (2008) 2.02

Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol (2007) 1.95

The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanoma. Ann Surg Oncol (2009) 1.93

The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer. Eur Urol (2011) 1.93

Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management. J Urol (2011) 1.72

Evaluation of current TNM classification of penile carcinoma. J Urol (2008) 1.63

Tumour thickness in oral cancer using an intra-oral ultrasound probe. Eur Radiol (2010) 1.58

Nodal staging in penile carcinoma by dynamic sentinel node biopsy after previous therapeutic primary tumour resection. Eur Urol (2010) 1.55

Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med (2012) 1.53

Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol (2007) 1.53

Prostate-sparing cystectomy: long-term oncological results. BJU Int (2009) 1.51

Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging (2014) 1.49

Accuracy of internal mammary lymph node localization using lymphoscintigraphy, sonography and CT. Radiother Oncol (2002) 1.45

Comparison of three micromorphometric pathology classifications of melanoma metastases in the sentinel node. Ann Surg (2009) 1.44

Size of metastasis in the sentinel node predicts additional nodal involvement in penile carcinoma. J Urol (2006) 1.43

Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol (2006) 1.43

Lymphatic mapping in patients with breast carcinoma: reproducibility of lymphoscintigraphic results. Radiology (2003) 1.43

Feasibility of sentinel node detection in renal cell carcinoma: a pilot study. Eur J Nucl Med Mol Imaging (2010) 1.42

Feasibility of sentinel node lymphoscintigraphy in stage I testicular cancer. Eur J Nucl Med Mol Imaging (2002) 1.42

Evaluation of (18)F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessment. J Thorac Oncol (2009) 1.41

Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities? Eur J Nucl Med Mol Imaging (2004) 1.41

Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol (2007) 1.40

Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J Nucl Med (2009) 1.33

Tumor response and toxicity of neoadjuvant erlotinib in patients with early-stage non-small-cell lung cancer. J Clin Oncol (2012) 1.28

Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients. Eur Urol (2010) 1.26

Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology (2005) 1.25

Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer. Ann Surg Oncol (2011) 1.25

Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol (2003) 1.20

Lymphadenectomy in the surgical management of penile cancer. Eur Urol (2009) 1.19

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery. World J Urol (2009) 1.19

Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer (2006) 1.18

Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature. Urology (2007) 1.18

131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging (2007) 1.18

Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid. Eur J Nucl Med Mol Imaging (2012) 1.15

Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol (2007) 1.15

Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis. J Clin Oncol (2009) 1.11

Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol (2003) 1.11

In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys (2004) 1.08

The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med (2007) 1.06

Radiofrequency ablation for treatment of sporadic angiomyolipoma. Urology (2008) 1.06

The Hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer. World J Surg (2008) 1.02

Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancer. Clin Cancer Res (2005) 1.01

Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol (2003) 1.01

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques. Breast Cancer Res Treat (2011) 1.00

Lymphatic drainage patterns from the treated breast. Ann Surg Oncol (2009) 0.99

A portable gamma-camera for intraoperative detection of sentinel nodes in the head and neck region. J Nucl Med (2010) 0.98

Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder. World J Urol (2008) 0.98

99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging (2007) 0.98

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer. Breast (2013) 0.97

Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int (2005) 0.96

Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases. Ann Surg Oncol (2010) 0.96

[Pregnancy following sexuality-preserving cystectomy for bladder carcinoma]. Ned Tijdschr Geneeskd (2011) 0.95

Penile cancer: organ-sparing techniques. BJU Int (2014) 0.95

Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol (2008) 0.95

Multimodal Surgical Guidance during Sentinel Node Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through Use of the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid. Radiology (2014) 0.95

Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review. World J Urol (2012) 0.95

Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentation. Urology (2012) 0.93

Hereditary causes of kidney tumours. Eur J Clin Invest (2010) 0.92

99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome. Nucl Med Commun (2008) 0.92

Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann Surg Oncol (2006) 0.92

Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol (2005) 0.92

Technological innovation in the sentinel node procedure: towards 3-D intraoperative imaging. Eur J Nucl Med Mol Imaging (2010) 0.91

Peroperative transrectal ultrasonography-guided bladder neck dissection eases the learning of robot-assisted laparoscopic prostatectomy. BJU Int (2008) 0.91

Heading toward radioactive seed localization in non-palpable breast cancer surgery? A meta-analysis. J Surg Oncol (2014) 0.90

The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer. Eur J Nucl Med Mol Imaging (2009) 0.90

Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients. J Nucl Med (2012) 0.90

Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med (2009) 0.90